Trials / Conditions / Adult T Acute Lymphoblastic Leukemia
Adult T Acute Lymphoblastic Leukemia
5 registered clinical trials studyying Adult T Acute Lymphoblastic Leukemia.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell A NCT02112916 | National Cancer Institute (NCI) | Phase 3 |
| Completed | Alisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-C NCT01567709 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Veliparib and Temozolomide in Treating Patients With Acute Leukemia NCT01139970 | National Cancer Institute (NCI) | Phase 1 |
| Active Not Recruiting | Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblas NCT00792948 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surg NCT00608361 | National Cancer Institute (NCI) | Phase 1 |